
Amit Sadanand Rao
About Amit Sadanand Rao
Data last updated:
Amit Sadanand Rao is a Whole-Time Director at Supreem Pharmaceuticals Mysore Private Limited (since 2020). The company operates in Healthcare. Supreem Pharmaceuticals Mysore Private Limited reported revenue of ₹82.17 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 10 Jul 2020 | 1996 | ₹82.17 Cr (FY 2025) | Active |
Board colleagues of Amit Sadanand Rao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aditya Sadanand Rao | 08766120 | Supreem Pharmaceuticals Mysore Private Limited | Whole-Time Director |
| Geetha Sadananda Nagaraja Rao | 01970187 | Supreem Pharmaceuticals Mysore Private Limited | Whole-Time Director |
| Sadanand Nagaraja Rao | 00390316 | Supreem Pharmaceuticals Mysore Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amit Sadanand Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amit Sadanand Rao
Amit Sadanand Rao currently holds 1 directorship: Supreem Pharmaceuticals Mysore Private Limited (Whole-Time Director, since 10 Jul 2020, revenue ₹82.17 Cr (FY 2025)).
Amit Sadanand Rao was first appointed on 10 Jul 2020 as Whole-Time Director at Supreem Pharmaceuticals Mysore Private Limited.
The current boards of Amit Sadanand Rao's companies include Aditya Sadanand Rao (Supreem Pharmaceuticals Mysore Private Limited), Geetha Sadananda Nagaraja Rao (Supreem Pharmaceuticals Mysore Private Limited), Sadanand Nagaraja Rao (Supreem Pharmaceuticals Mysore Private Limited).